Pharmacokinetic Drug Interactions of the New Oral Anticoagulants Revisited

2021 ◽  
Author(s):  
Hillel Halkin
Keyword(s):  
Drug Interactions ◽  
Oral Anticoagulants ◽  
New Oral Anticoagulants ◽  
Pharmacokinetic Drug

Drug interactions of new oral anticoagulants: View of a clinical pharmacologist

2016 ◽  
Vol 15 (5) ◽  
pp. 335-341
Author(s):  
D. A. Sychev ◽  
◽  
K. B. Mirzaev ◽  
A. N. Levanov ◽  
◽  
...  
Keyword(s):  
Drug Interactions ◽  
Oral Anticoagulants ◽  
New Oral Anticoagulants ◽  
Clinical Pharmacologist

scholarly journals Old and new oral anticoagulants: Food, herbal medicines and drug interactions

Blood Reviews ◽  
2017 ◽  
Vol 31 (4) ◽  
pp. 193-203 ◽  
Author(s):  
Alessandro Di Minno ◽  
Beatrice Frigerio ◽  
Gaia Spadarella ◽  
Alessio Ravani ◽  
Daniela Sansaro ◽  
...  
Keyword(s):  
Drug Interactions ◽  
Oral Anticoagulants ◽  
Herbal Medicines ◽  
New Oral Anticoagulants

Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)

2018 ◽  
Vol 135 ◽  
pp. 60-79 ◽  
Author(s):  
Paolo Gelosa ◽  
Laura Castiglioni ◽  
Marco Tenconi ◽  
Ludovico Baldessin ◽  
Giorgio Racagni ◽  
...  
Keyword(s):  
Drug Interactions ◽  
Vitamin K ◽  
Oral Anticoagulants ◽  
Vitamin K Antagonist ◽  
Pharmacokinetic Drug

scholarly journals Treatment with new oral anticoagulants in the family medicine practice

2015 ◽  
Vol 10 (4) ◽  
pp. 329-332
Author(s):  
Camelia DIACONU ◽  
◽  
Giorgiana DEDIU ◽  
Mădălina ILIE ◽  
Mihaela Adela IANCU ◽  
...  
Keyword(s):  
Drug Interactions ◽  
Vitamin K ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
Rapid Onset ◽  
New Oral Anticoagulants ◽  
Anticoagulant Treatment ◽  
Oral Anticoagulant Treatment ◽  
Rapid Clearance ◽  
Concomitant Medications

Vitamin K antagonists represented for more than 50 years the only oral anticoagulant treatment option, though encumbered by numerous food and drug interactions, with direct impact on the safety and efficacy of this treatment. The frequent complications of anticoagulant treatment with vitamin K antagonists led to the need for the emergence of new oral anticoagulants (NOAC). The main NOACs used today are dabigatran, rivaroxaban and apixaban. NOAC have a number of advantages over antivitamin K anticoagulants: fewer drug interactions, no food interactions, rapid onset of the anticoagulant action, rapid clearance, no need for INR monitoring. NOAC therapy must be individualized according to patient age, comorbidities and medical history, renal function, concomitant medications. Given that clinical experience with NOAC is still limited in practice, physicians (including family physicians) must monitor these patients and need to pay attention and report any side effects.

Clinical Management of Pharmacokinetic Drug Interactions with Direct Oral Anticoagulants (DOACs)

Drugs ◽  
2019 ◽  
Vol 79 (15) ◽  
pp. 1625-1634 ◽  
Author(s):  
Megan C. Herink ◽  
Yan F. Zhuo ◽  
Craig D. Williams ◽  
Thomas G. DeLoughery
Keyword(s):  
Drug Interactions ◽  
Clinical Management ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Pharmacokinetic Drug

scholarly journals Drug-drug interactions with the new oral anticoagulants

2014 ◽  
Vol 20 (1-2) ◽  
pp. 20
Author(s):  
Virginia Tzankova ◽  
Veselin Petrov
Keyword(s):  
Drug Interactions ◽  
Oral Anticoagulants ◽  
New Oral Anticoagulants
Sign in / Sign up

Export Citation Format

Share Document